Financial Ratios Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01031

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 01:43:25 2026-01-14 am EST			5-day change	1st Jan Change
1,183.40 ^INR	-0.58%		-4.76%	-6.90%

Jan. 13	Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading	MT
Jan. 13	Global drugmakers rush to boost US presence as tariff threat looms	RE

57be4fd.BuBfsYLGLY_dOVMV8UoBYG3nSnC0XGrfQNiY_IEji3k.c646y8r_VLi6SRlygSN5MUCgDRLSPTWFbY_tiOVPuzJZjwji25EZxrIONA

Published financial data: DR. REDDY'S LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	190B	214B	246B	279B	326B
Total Revenues	190B	214B	246B	279B	326B
Cost of Goods Sold, Total	86.64B	101B	107B	116B	135B
Gross Profit	103B	114B	139B	164B	190B
Selling General & Admin Expenses, Total	54.59B	62.08B	68.03B	77.2B	92.85B
R&D Expenses	16.54B	17.48B	19.38B	22.87B	27.38B
Other Operating Expenses	-1.02B	-1.64B	-1.48B	-1.78B	-2.84B
Other Operating Expenses, Total	70.11B	77.92B	85.93B	98.3B	117B
Operating Income	32.97B	35.92B	53.42B	65.31B	73.03B
Interest Expense, Total	-970M	-958M	-1.43B	-1.71B	-2.83B
Interest And Investment Income	826M	965M	1.18B	2.28B	2.68B
Net Interest Expenses	-144M	7M	-248M	567M	-152M
Income (Loss) On Equity Invest.	480M	703M	370M	147M	217M
Currency Exchange Gains (Loss)	1.24B	1.84B	2.22B	278M	1.32B
Other Non Operating Income (Expenses)	-	-	-	46M	3.55B
EBT, Excl. Unusual Items	34.55B	38.46B	55.76B	66.35B	77.97B
Merger & Related Restructuring Charges	-60M	-	-	-	-1.02B
Gain (Loss) On Sale Of Investments	557M	277M	876M	3.1B	-
Gain (Loss) On Sale Of Assets	-42M	1.12B	-1.21B	900M	1.52B
Asset Writedown	-8.59B	-7.56B	-699M	-3M	-1.69B
Legal Settlements	-	-	5.64B	1.52B	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	26.41B	32.3B	60.37B	71.87B	76.78B
Income Tax Expense	9.18B	8.73B	15.3B	16.19B	19.54B
Earnings From Continuing Operations	17.24B	23.57B	45.07B	55.68B	57.24B
Net Income to Company	17.24B	23.57B	45.07B	55.68B	57.24B
Minority Interest	-	-	-	-	-701M
Net Income - (IS)	17.24B	23.57B	45.07B	55.68B	56.54B
Net Income to Common Incl Extra Items	17.24B	23.57B	45.07B	55.68B	56.54B
Net Income to Common Excl. Extra Items	17.24B	23.57B	45.07B	55.68B	56.54B
Per Share Items
Net EPS - Basic	20.79	28.42	54.29	66.93	67.88
Basic EPS - Continuing Operations	20.79	28.42	54.29	66.93	67.88
Basic Weighted Average Shares Outstanding	829M	829M	830M	832M	833M
Net EPS - Diluted	20.73	28.34	54.17	66.8	67.78
Diluted EPS - Continuing Operations	20.73	28.34	54.17	66.8	67.78
Diluted Weighted Average Shares Outstanding	832M	832M	832M	834M	834M
Normalized Basic EPS	26.04	28.98	41.98	49.84	57.66
Normalized Diluted EPS	25.96	28.9	41.89	49.75	57.58
Dividend Per Share	5	6	8	8	8
Payout Ratio	24.06	17.59	11.05	11.94	11.78
American Depositary Receipts Ratio (ADR)	0.17	0.17	0.17	0.17	0.17
Supplemental Items
EBITDA	44.94B	46.88B	65.17B	79.01B	88.84B
EBITA	37.24B	39.59B	57.44B	70.57B	79.58B
EBIT	32.97B	35.92B	53.42B	65.31B	73.03B
EBITDAR	-	-	-	79.04B	88.88B
Effective Tax Rate - (Ratio)	34.74	27.03	25.34	22.52	25.45
Current Domestic Taxes	5.85B	4.18B	8.77B	13.87B	17.91B
Current Foreign Taxes	2.32B	2.23B	4.09B	5.58B	4.67B
Total Current Taxes	8.17B	6.41B	12.86B	19.46B	22.58B
Deferred Domestic Taxes	2.74B	2.16B	3.89B	968M	-1.07B
Deferred Foreign Taxes	-1.73B	154M	-1.45B	-4.24B	-1.97B
Total Deferred Taxes	1B	2.32B	2.44B	-3.27B	-3.04B
Normalized Net Income	21.59B	24.04B	34.85B	41.47B	48.03B
Interest Capitalized	415M	421M	426M	488M	729M
Interest on Long-Term Debt	227M	221M	214M	256M	391M
Non-Cash Pension Expense	16M	43M	51M	-4M	19M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	16.54B	17.48B	19.38B	22.87B	27.38B
Net Rental Expense, Total	-	-	-	37M	39M
Imputed Operating Lease Interest Expense	-	-	-	38.87M	33.24M
Imputed Operating Lease Depreciation	-	-	-	-1.87M	5.76M
Stock-Based Comp., Other (Total)	741M	740M	644M	821M	796M
Total Stock-Based Compensation	741M	740M	644M	821M	796M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.83B	14.85B	5.78B	7.11B	14.65B
Short Term Investments	19.74B	29.51B	56.02B	74.36B	43.25B
Total Cash And Short Term Investments	34.57B	44.36B	61.8B	81.47B	57.91B
Accounts Receivable, Total	49.64B	66.76B	72.48B	80.3B	90.42B
Other Receivables	4.82B	5.05B	3.28B	2.91B	2.97B
Total Receivables	54.46B	71.82B	75.77B	83.21B	93.39B
Inventory	45.41B	50.88B	48.67B	63.55B	71.08B
Prepaid Expenses	1.14B	1.14B	1.45B	1.95B	1.88B
Other Current Assets, Total	12.67B	13.65B	19.25B	17.87B	25.85B
Total Current Assets	148B	182B	207B	248B	250B
Gross Property Plant And Equipment	128B	142B	152B	170B	190B
Accumulated Depreciation	-70.56B	-79.73B	-85.81B	-93.26B	-92.62B
Net Property Plant And Equipment	57.11B	62.17B	66.46B	76.89B	97.76B
Long-term Investments	8.33B	7.99B	5.36B	5.26B	15.2B
Goodwill	4.57B	4.42B	4.24B	4.25B	11.81B
Other Intangibles, Total	35.65B	27.25B	30.85B	36.95B	96.8B
Accounts Receivable Long-Term	118M	54M	-	-	-
Deferred Tax Assets Long-Term	10.63B	8.2B	7.2B	10.77B	18.51B
Other Long-Term Assets, Total	834M	894M	800M	5.35B	2.79B
Total Assets	265B	293B	322B	388B	493B
Liabilities
Accounts Payable, Total	12.7B	15.97B	17.86B	21.55B	20.05B
Accrued Expenses, Total	31.81B	36.08B	38.72B	40.49B	43.86B
Short-term Borrowings	23.14B	27.08B	7.39B	12.72B	38.04B
Current Portion of Long-Term Debt	-	-	3.8B	-	-
Current Portion of Leases	864M	1.02B	1B	1.31B	857M
Current Income Taxes Payable	1.39B	1.62B	2.14B	2.34B	3.03B
Unearned Revenue Current, Total	2.03B	2.58B	1.98B	1.44B	1.98B
Other Current Liabilities	11.46B	9.67B	12.95B	16.19B	22.56B
Total Current Liabilities	83.39B	94.02B	85.84B	96.04B	130B
Long-Term Debt	3.8B	3.8B	-	3.8B	3.8B
Long-Term Leases	2.5B	1.95B	1.28B	2.19B	4.06B
Unearned Revenue Non Current	1.53B	1.6B	1.56B	1.19B	1.16B
Deferred Tax Liability Non Current	338M	60M	833M	909M	14.11B
Other Non Current Liabilities	870M	882M	1.35B	2.84B	2.3B
Total Liabilities	92.43B	102B	90.86B	107B	156B
Common Stock, Total	832M	832M	833M	834M	834M
Additional Paid In Capital	8.89B	9.28B	9.69B	10.76B	11.13B
Retained Earnings	157B	176B	216B	266B	316B
Treasury Stock	-1.97B	-1.6B	-1.27B	-991M	-2.26B
Comprehensive Income and Other	7.96B	5.55B	5.26B	4.03B	7.89B
Total Common Equity	173B	191B	231B	281B	333B
Minority Interest	-	-	-	-	3.78B
Total Equity	173B	191B	231B	281B	337B
Total Liabilities And Equity	265B	293B	322B	388B	493B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	829M	830M	831M	833M	832M
ECS Total Common Shares Outstanding	829M	830M	831M	833M	832M
Book Value / Share	208.85	229.61	278.04	336.94	400.71
Tangible Book Value	133B	159B	196B	239B	225B
Tangible Book Value Per Share	160.32	191.45	235.8	287.45	270.16
Total Debt	30.31B	33.84B	13.47B	20.02B	46.77B
Net Debt	-4.26B	-10.52B	-48.32B	-61.45B	-11.14B
Debt Equivalent of Unfunded Proj. Benefit Obligation	769M	600M	26M	357M	524M
Debt Equivalent Oper. Leases	-	-	-	296M	312M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	3.78B
Equity Method Investments, Total	3.38B	4.32B	4.7B	4.2B	4.81B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	15.57B	17.51B	16B	24.08B	26.16B
Inventories - Work In Process, Total	10.01B	12.89B	11.7B	14.22B	16.52B
Inventories - Finished Goods, Total	19.83B	20.49B	20.97B	25.25B	28.4B
Land - (BS)	4.15B	4.15B	4.23B	4.22B	4.16B
Buildings, Total	23.63B	24.66B	26.52B	27.99B	28.34B
Machinery, Total	85.47B	95.1B	107B	117B	125B
Full Time Employees	22.74K	24.8K	25.86K	27.05K	27.81K
Accumulated Allowance for Doubtful Accounts (Supple)	1.3B	1.19B	1.26B	1.45B	1.48B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	17.24B	23.57B	45.07B	55.68B	56.54B
Depreciation & Amortization - CF	8.53B	8.15B	8.62B	9.58B	10.5B
Amortization of Goodwill and Intangible Assets - (CF)	4.27B	3.67B	4.02B	5.26B	6.55B
Depreciation & Amortization, Total	12.8B	11.82B	12.64B	14.84B	17.06B
(Gain) Loss From Sale Of Asset	42M	-1.12B	208M	-900M	-1.52B
(Gain) Loss on Sale of Investments - (CF)	-557M	-277M	-876M	-3.15B	-3.55B
Asset Writedown & Restructuring Costs	8.59B	7.56B	699M	3M	1.69B
(Income) Loss On Equity Investments - (CF)	-480M	-703M	-370M	-147M	-217M
Stock-Based Compensation (CF)	584M	592M	397M	407M	424M
Provision and Write-off of Bad Debts	230M	55M	205M	275M	161M
Other Operating Activities, Total	5.46B	520M	8.76B	-1.4B	5.83B
Change In Accounts Receivable	2.08B	-17.01B	-5.75B	-8.05B	-10.28B
Change In Inventories	-9.88B	-5.33B	-2.65B	-18.44B	-12.75B
Change In Accounts Payable	2.86B	4.41B	23M	3.46B	340M
Change in Other Net Operating Assets	-3.26B	4.01B	528M	2.86B	-7.29B
Cash from Operations	35.7B	28.11B	58.88B	45.43B	46.43B
Capital Expenditure	-9.74B	-14.66B	-11.32B	-16.4B	-27.5B
Sale of Property, Plant, and Equipment	85M	370M	82M	1.06B	512M
Cash Acquisitions	-15.51B	-326M	-	-	-53.1B
Sale (Purchase) of Intangible assets	-2.82B	-1.44B	-7.54B	-11.01B	-6.16B
Investment in Marketable and Equity Securities, Total	4.11B	-11.2B	-23.37B	-15.72B	24.8B
Other Investing Activities, Total	1.22B	873M	777M	1.78B	3.37B
Cash from Investing	-22.66B	-26.39B	-41.37B	-40.28B	-58.08B
Short Term Debt Issued, Total	6.79B	3.52B	-	5.49B	24.49B
Long-Term Debt Issued, Total	3.8B	-	-	3.8B	-
Total Debt Issued	10.59B	3.52B	-	9.29B	24.49B
Short Term Debt Repaid, Total	-	-	-19.38B	-	-
Long-Term Debt Repaid, Total	-4.5B	-785M	-1.02B	-4.95B	-1.29B
Total Debt Repaid	-4.5B	-785M	-20.4B	-4.95B	-1.29B
Issuance of Common Stock	269M	334M	368M	805M	193M
Repurchase of Common Stock	-1.19B	-	-	-	-1.39B
Common Dividends Paid	-4.15B	-4.15B	-4.98B	-6.65B	-6.66B
Common & Preferred Stock Dividends Paid	-4.15B	-4.15B	-4.98B	-6.65B	-6.66B
Other Financing Activities, Total	-1.32B	-1.34B	-1.85B	-2.27B	3.57B
Cash from Financing	-298M	-2.42B	-26.86B	-3.76B	18.91B
Foreign Exchange Rate Adjustments	113M	733M	286M	-59M	224M
Net Change in Cash	12.86B	32M	-9.07B	1.33B	7.49B
Supplemental Items
Cash Interest Paid	1.32B	1.34B	1.85B	2.27B	3.48B
Cash Income Tax Paid (Refund)	5.72B	7.44B	10.71B	20.05B	19.99B
Levered Free Cash Flow	19.3B	1.03B	26.99B	12.23B	11.92B
Unlevered Free Cash Flow	19.9B	1.63B	27.88B	13.3B	13.69B
Change In Net Working Capital	1.68B	17.28B	-83M	15.76B	16.14B
Net Debt Issued / Repaid	6.09B	2.74B	-20.4B	4.35B	23.2B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.28	8.04	10.86	11.51	10.37
Return on Total Capital	10.83	10.5	14.24	14.98	13.34
Return On Equity %	10.51	12.96	21.38	21.77	18.53
Return on Common Equity	10.51	12.96	21.38	21.77	18.42
Margin Analysis
Gross Profit Margin %	54.33	53.1	56.67	58.61	58.5
SG&A Margin	28.77	28.96	27.67	27.65	28.52
EBITDA Margin %	23.68	21.87	26.51	28.3	27.29
EBITA Margin %	19.63	18.47	23.36	25.28	24.45
EBIT Margin %	17.38	16.75	21.72	23.39	22.43
Income From Continuing Operations Margin %	9.09	10.99	18.33	19.95	17.58
Net Income Margin %	9.09	10.99	18.33	19.95	17.37
Net Avail. For Common Margin %	9.09	10.99	18.33	19.95	17.37
Normalized Net Income Margin	11.38	11.21	14.17	14.85	14.75
Levered Free Cash Flow Margin	10.17	0.48	10.98	4.38	3.66
Unlevered Free Cash Flow Margin	10.49	0.76	11.34	4.76	4.2
Asset Turnover
Asset Turnover	0.76	0.77	0.8	0.79	0.74
Fixed Assets Turnover	3.47	3.59	3.82	3.89	3.73
Receivables Turnover (Average Receivables)	3.8	3.68	3.53	3.65	3.81
Inventory Turnover (Average Inventory)	2.15	2.09	2.14	2.06	2.01
Short Term Liquidity
Current Ratio	1.78	1.93	2.41	2.58	1.92
Quick Ratio	1.07	1.24	1.6	1.71	1.16
Operating Cash Flow to Current Liabilities	0.43	0.3	0.69	0.47	0.36
Days Sales Outstanding (Average Receivables)	96.12	99.09	103.36	100.15	95.71
Days Outstanding Inventory (Average Inventory)	169.51	174.78	170.54	177.72	181.86
Average Days Payable Outstanding	44.11	49.35	59.18	55.28	53.22
Cash Conversion Cycle (Average Days)	221.52	224.52	214.72	222.59	224.35
Long Term Solvency
Total Debt/Equity	17.51	17.76	5.83	7.14	13.87
Total Debt / Total Capital	14.9	15.08	5.51	6.66	12.18
LT Debt/Equity	3.64	3.02	0.55	2.14	2.33
Long-Term Debt / Total Capital	3.1	2.56	0.52	1.99	2.05
Total Liabilities / Total Assets	34.81	34.94	28.23	27.6	31.61
EBIT / Interest Expense	33.99	37.49	37.41	38.17	25.82
EBITDA / Interest Expense	47.18	49.84	46.25	46.84	31.84
(EBITDA - Capex) / Interest Expense	37.14	34.53	38.33	37.26	22.12
Total Debt / EBITDA	0.66	0.71	0.2	0.25	0.52
Net Debt / EBITDA	-0.09	-0.22	-0.73	-0.77	-0.12
Total Debt / (EBITDA - Capex)	0.84	1.02	0.25	0.31	0.75
Net Debt / (EBITDA - Capex)	-0.12	-0.32	-0.88	-0.96	-0.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.66	13	14.69	13.54	16.61
Gross Profit, 1 Yr. Growth %	9.65	10.44	22.4	17.41	16.39
EBITDA, 1 Yr. Growth %	8.82	4.34	39.01	21.22	12.05
EBITA, 1 Yr. Growth %	12.35	6.32	45.08	22.87	12.32
EBIT, 1 Yr. Growth %	12.48	8.94	48.71	22.26	11.35
Earnings From Cont. Operations, 1 Yr. Growth %	-11.59	36.72	91.22	23.56	2.8
Net Income, 1 Yr. Growth %	-11.59	36.72	91.22	23.56	1.54
Normalized Net Income, 1 Yr. Growth %	13.55	11.34	44.97	19.3	10.21
Diluted EPS Before Extra, 1 Yr. Growth %	-11.71	36.7	91.16	23.32	1.47
Accounts Receivable, 1 Yr. Growth %	-1.27	34.49	8.57	10.78	12.61
Inventory, 1 Yr. Growth %	29.5	12.05	-4.35	30.58	11.85
Net Property, Plant and Equip., 1 Yr. Growth %	9.13	8.86	6.91	15.68	27.15
Total Assets, 1 Yr. Growth %	14.32	10.3	9.91	20.4	27.22
Tangible Book Value, 1 Yr. Growth %	7.71	19.58	23.31	22.18	-6.09
Common Equity, 1 Yr. Growth %	11.66	10.09	21.24	21.45	18.83
Cash From Operations, 1 Yr. Growth %	19.64	-21.27	109.46	-22.83	2.19
Capital Expenditures, 1 Yr. Growth %	101.01	50.5	-22.76	44.86	67.68
Levered Free Cash Flow, 1 Yr. Growth %	2.92	-94.66	2.52K	-58.79	-3.92
Unlevered Free Cash Flow, 1 Yr. Growth %	2.79	-91.81	1.61K	-56.49	1.58
Dividend Per Share, 1 Yr. Growth %	0	20	33.33	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.05	10.81	13.84	14.11	15.06
Gross Profit, 2 Yr. CAGR %	11.15	10.04	16.27	19.88	16.9
EBITDA, 2 Yr. CAGR %	18.75	5.93	19.41	28.64	15.97
EBITA, 2 Yr. CAGR %	25.87	9.29	24.29	33.51	17.71
EBIT, 2 Yr. CAGR %	29.45	10.7	27.4	34.84	16.93
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.23	9.94	61.69	53.71	12.7
Net Income, 2 Yr. CAGR %	-4.23	9.94	61.69	53.71	12.01
Normalized Net Income, 2 Yr. CAGR %	29.95	12.44	26.15	30.86	16.48
Diluted EPS Before Extra, 2 Yr. CAGR %	-4.26	9.86	61.65	53.54	11.86
Accounts Receivable, 2 Yr. CAGR %	11.58	15.23	20.84	9.67	11.69
Inventory, 2 Yr. CAGR %	16.29	20.46	3.52	11.76	20.85
Net Property, Plant and Equip., 2 Yr. CAGR %	2.76	8.99	7.88	11.21	21.28
Total Assets, 2 Yr. CAGR %	8.52	12.29	10.1	15.04	23.76
Tangible Book Value, 2 Yr. CAGR %	20.21	13.49	21.43	22.74	7.12
Common Equity, 2 Yr. CAGR %	11.1	10.87	15.53	21.35	20.14
Cash From Operations, 2 Yr. CAGR %	11.53	-2.95	28.41	27.14	-11.2
Capital Expenditures, 2 Yr. CAGR %	18.35	73.93	7.81	5.78	55.85
Levered Free Cash Flow, 2 Yr. CAGR %	13.05	-76.55	18.38	244.49	-36.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	12.75	-70.99	18.47	185.71	-33.08
Dividend Per Share, 2 Yr. CAGR %	11.8	9.54	26.49	15.47	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.18	11.7	12.09	13.74	14.94
Gross Profit, 3 Yr. CAGR %	10.54	10.92	14.02	16.65	18.71
EBITDA, 3 Yr. CAGR %	23.71	13.74	15.97	20.01	23
EBITA, 3 Yr. CAGR %	34.08	18.98	20.11	23.82	26.2
EBIT, 3 Yr. CAGR %	39.96	22.22	22.14	25.66	26.69
Earnings From Cont. Operations, 3 Yr. CAGR %	20.69	7.84	32.22	47.82	34.42
Net Income, 3 Yr. CAGR %	20.69	7.84	32.22	47.82	33.87
Normalized Net Income, 3 Yr. CAGR %	41.56	23.43	22.38	23.71	25.65
Diluted EPS Before Extra, 3 Yr. CAGR %	20.66	7.8	32.14	47.71	33.73
Accounts Receivable, 3 Yr. CAGR %	6.92	18.75	12.97	17.39	10.64
Inventory, 3 Yr. CAGR %	16.01	14.86	11.55	11.85	11.79
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.44	4.75	8.29	10.42	16.29
Total Assets, 3 Yr. CAGR %	5.58	9.11	11.49	13.44	18.96
Tangible Book Value, 3 Yr. CAGR %	19.5	20	16.68	21.68	12.26
Common Equity, 3 Yr. CAGR %	11.02	10.77	14.23	17.47	20.5
Cash From Operations, 3 Yr. CAGR %	25.58	-0.7	25.42	8.36	18.21
Capital Expenditures, 3 Yr. CAGR %	1.59	28.22	32.7	18.97	23.34
Levered Free Cash Flow, 3 Yr. CAGR %	62.02	-59.13	12.91	-14.04	126.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	58.17	-52.96	12.92	-12.52	103.29
Dividend Per Share, 3 Yr. CAGR %	7.72	14.47	16.96	16.96	10.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.28	8.92	11.63	12.66	13.27
Gross Profit, 5 Yr. CAGR %	2.24	7.76	12.8	14.42	15.16
EBITDA, 5 Yr. CAGR %	2.26	13.82	22.39	19.91	16.28
EBITA, 5 Yr. CAGR %	2.2	18.49	30.03	24.6	19.15
EBIT, 5 Yr. CAGR %	1.96	22.03	34.75	27.12	20.03
Earnings From Cont. Operations, 5 Yr. CAGR %	-2.94	14.38	35.67	24.26	24.04
Net Income, 5 Yr. CAGR %	-2.94	14.38	35.67	24.26	23.73
Normalized Net Income, 5 Yr. CAGR %	2.05	23.35	35.56	26.53	20.36
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.39	14.47	35.64	24.19	23.62
Accounts Receivable, 5 Yr. CAGR %	3.74	11.89	12.28	15.03	12.45
Inventory, 5 Yr. CAGR %	12.17	12.27	10.84	13.61	15.18
Net Property, Plant and Equip., 5 Yr. CAGR %	1.14	1.69	2.81	7.29	13.31
Total Assets, 5 Yr. CAGR %	5.04	5.9	7.36	11.44	16.25
Tangible Book Value, 5 Yr. CAGR %	5.08	16.08	20.27	21.09	12.75
Common Equity, 5 Yr. CAGR %	6.16	8.96	12.8	14.88	16.55
Cash From Operations, 5 Yr. CAGR %	-2.85	5.49	26.7	9.62	9.24
Capital Expenditures, 5 Yr. CAGR %	-4.11	3.61	4.04	18.72	41.52
Levered Free Cash Flow, 5 Yr. CAGR %	-1.8	-46.93	42.85	-4.13	-8.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.66	-41.64	40.85	-3.21	-6.7
Dividend Per Share, 5 Yr. CAGR %	4.56	8.45	14.87	14.87	9.86